RIFAMPICIN AND IMMUNOSUPPRESSION

RIFAMPICIN AND IMMUNOSUPPRESSION

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 1974-07, Vol.304 (7873), p.172-172
1. Verfasser: Serrou, B.
Format: Artikel
Sprache:eng
Schlagworte:
Biopsy
Cancer therapies
Cell cycle
Classification
Cytotoxicity
Drug dosages
Immunosuppression
Lymphocytes
Metabolites
Rifampin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 172
container_issue 7873
container_start_page 172
container_title The Lancet (British edition)
container_volume 304
creator Serrou, B.
description
doi_str_mv 10.1016/S0140-6736(74)91611-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2151726459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673674916110</els_id><sourcerecordid>2151726459</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-f028e158f952c51c78c98f2fa0dfeaa4d2e448f74ad9c2386d670b4d73579c353</originalsourceid><addsrcrecordid>eNqFkEtLw0AUhQdRsFZ_ghBwo4vovZN5JCspfWigTUtjwN0Q5wEp2tSZVvDfm7bi1tXdfOdczkfINcI9AoqHEpBBLGQibiW7y1AgxnBCesgkizmTr6ek94eck4sQVgDABPAeiZb5ZDBb5MO8iAbFKMpns6qYl9VisRyXZT4vLsmZq9-Dvfq9fVJNxi_D53g6f8qHg2msqaTb2AFNLfLUZZxqjlqmOksddTUYZ-uaGWoZS51ktck0TVJhhIQ3ZmTCZaYTnvTJzbF349vPnQ1btWp3ft29VBQ5SioYzzqKHynt2xC8dWrjm4_afysEtZehDjLUfqmSTB1kKOhyj8ec7SZ8NdaroBu71tY03uqtMm3zT8MPub9heg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2151726459</pqid></control><display><type>article</type><title>RIFAMPICIN AND IMMUNOSUPPRESSION</title><source>Elsevier ScienceDirect Journals</source><creator>Serrou, B.</creator><creatorcontrib>Serrou, B.</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(74)91611-0</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Biopsy ; Cancer therapies ; Cell cycle ; Classification ; Cytotoxicity ; Drug dosages ; Immunosuppression ; Lymphocytes ; Metabolites ; Rifampin</subject><ispartof>The Lancet (British edition), 1974-07, Vol.304 (7873), p.172-172</ispartof><rights>1974</rights><rights>Copyright Elsevier Limited Jul 20, 1974</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c272t-f028e158f952c51c78c98f2fa0dfeaa4d2e448f74ad9c2386d670b4d73579c353</citedby><cites>FETCH-LOGICAL-c272t-f028e158f952c51c78c98f2fa0dfeaa4d2e448f74ad9c2386d670b4d73579c353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673674916110$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids></links><search><creatorcontrib>Serrou, B.</creatorcontrib><title>RIFAMPICIN AND IMMUNOSUPPRESSION</title><title>The Lancet (British edition)</title><subject>Biopsy</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Classification</subject><subject>Cytotoxicity</subject><subject>Drug dosages</subject><subject>Immunosuppression</subject><subject>Lymphocytes</subject><subject>Metabolites</subject><subject>Rifampin</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1974</creationdate><recordtype>article</recordtype><recordid>eNqFkEtLw0AUhQdRsFZ_ghBwo4vovZN5JCspfWigTUtjwN0Q5wEp2tSZVvDfm7bi1tXdfOdczkfINcI9AoqHEpBBLGQibiW7y1AgxnBCesgkizmTr6ek94eck4sQVgDABPAeiZb5ZDBb5MO8iAbFKMpns6qYl9VisRyXZT4vLsmZq9-Dvfq9fVJNxi_D53g6f8qHg2msqaTb2AFNLfLUZZxqjlqmOksddTUYZ-uaGWoZS51ktck0TVJhhIQ3ZmTCZaYTnvTJzbF349vPnQ1btWp3ft29VBQ5SioYzzqKHynt2xC8dWrjm4_afysEtZehDjLUfqmSTB1kKOhyj8ec7SZ8NdaroBu71tY03uqtMm3zT8MPub9heg</recordid><startdate>19740720</startdate><enddate>19740720</enddate><creator>Serrou, B.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>KB~</scope><scope>M7N</scope><scope>NAPCQ</scope></search><sort><creationdate>19740720</creationdate><title>RIFAMPICIN AND IMMUNOSUPPRESSION</title><author>Serrou, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-f028e158f952c51c78c98f2fa0dfeaa4d2e448f74ad9c2386d670b4d73579c353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1974</creationdate><topic>Biopsy</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Classification</topic><topic>Cytotoxicity</topic><topic>Drug dosages</topic><topic>Immunosuppression</topic><topic>Lymphocytes</topic><topic>Metabolites</topic><topic>Rifampin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serrou, B.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Newsstand Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serrou, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RIFAMPICIN AND IMMUNOSUPPRESSION</atitle><jtitle>The Lancet (British edition)</jtitle><date>1974-07-20</date><risdate>1974</risdate><volume>304</volume><issue>7873</issue><spage>172</spage><epage>172</epage><pages>172-172</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.1016/S0140-6736(74)91611-0</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1974-07, Vol.304 (7873), p.172-172
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_journals_2151726459
source Elsevier ScienceDirect Journals
subjects Biopsy
Cancer therapies
Cell cycle
Classification
Cytotoxicity
Drug dosages
Immunosuppression
Lymphocytes
Metabolites
Rifampin
title RIFAMPICIN AND IMMUNOSUPPRESSION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T08%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RIFAMPICIN%20AND%20IMMUNOSUPPRESSION&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Serrou,%20B.&rft.date=1974-07-20&rft.volume=304&rft.issue=7873&rft.spage=172&rft.epage=172&rft.pages=172-172&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(74)91611-0&rft_dat=%3Cproquest_cross%3E2151726459%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2151726459&rft_id=info:pmid/&rft_els_id=S0140673674916110&rfr_iscdi=true